Anetumab ravtansine

Tidak ditemukan merek terdaftar untuk zat aktif ini.

Tidak ada catatan makanan tercatat untuk zat aktif ini.

• AbciximabMODERAT

  Mengonsumsi Abciximab bersama Anetumab ravtansine dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Abciximab is combined with Anetumab ravtansine.

• AbituzumabMODERAT

  Mengonsumsi Abituzumab bersama Anetumab ravtansine dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Abituzumab is combined with Anetumab ravtansine.

• AdalimumabMODERAT

  Mengonsumsi Adalimumab bersama Anetumab ravtansine dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Adalimumab is combined with Anetumab ravtansine.

• AdecatumumabMODERAT

  Mengonsumsi Adecatumumab bersama Anetumab ravtansine dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Adecatumumab is combined with Anetumab ravtansine.

• AducanumabMODERAT

  Mengonsumsi Aducanumab bersama Anetumab ravtansine dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Aducanumab is combined with Anetumab ravtansine.

• AfelimomabMODERAT

  Mengonsumsi Afelimomab bersama Anetumab ravtansine dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Afelimomab is combined with Anetumab ravtansine.

• AlemtuzumabMODERAT

  Mengonsumsi Alemtuzumab bersama Anetumab ravtansine dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Anetumab ravtansine.

• AlirocumabMODERAT

  Mengonsumsi Alirocumab bersama Anetumab ravtansine dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Alirocumab is combined with Anetumab ravtansine.

• AmatuximabMODERAT

  Mengonsumsi Amatuximab bersama Anetumab ravtansine dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Amatuximab is combined with Anetumab ravtansine.

• AMG 108MODERAT

  Mengonsumsi AMG 108 bersama Anetumab ravtansine dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when AMG 108 is combined with Anetumab ravtansine.